Comparison of microneedles and adhesive-tape stripping in skin preparation for epicutaneous allergen delivery

International Archives of Allergy and Immunology

Volumn 167, Issue 2, 2015, Pages 103-109

  Spina, Lara ^a   Weisskopf, Michael ^c   Von Moos, Seraina ^a   Graf, Nicole ^b   Kündig, Thomas M ^a   Senti, Gabriela ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Graf Biostatistics   (Switzerland)

^c CRS Clinical Research Services Andernach GmbH   (Germany)

Author keywords

Epicutaneous allergen specific immunotherapy; Microneedles; Transcutaneous immunotherapy

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ADHESIVE TAPE STRIPPING; ARTICLE; BIRCH; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; DIFFUSION; DILUTION; ECZEMA; FOREARM; HEADACHE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGICAL PROCEDURES; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; LOCAL SKIN REACTION; MAST CELL; MICRONEEDLE; POLLEN ALLERGY; PRICK TEST; PRIORITY JOURNAL; SINGLE PRICK LANCET PIERCING; STRATUM CORNEUM; URTICARIA; ADOLESCENT; ADULT; ADVERSE EFFECTS; DESENSITIZATION; DEVICES; FEMALE; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEEDLE; POLLEN; PROCEDURES; RHINITIS, ALLERGIC, SEASONAL; SKIN TEST; SURGICAL TAPE; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ALLERGENS; BETULA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; NEEDLES; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; SURGICAL TAPE; YOUNG ADULT;

EID: 84939493769     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000434681     Document Type: Article

References (33)

1. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743
2. Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 2009; 8: 645-660
3. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008; 8: 218-230
4. Frew AJ. Allergen immunotherapy. J Allergy Clin Immunol 2010; 125: S306-S313
5. Moreno C, Cuesta-Herranz J, Fernandez-Tavora L, Alvarez-Cuesta E. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004; 34: 527-531
6. Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117: 1021-1035
7. Senna G, Lombardi C, Canonica GW, Passalacqua G. How adherent to sublingual immunotherapy prescriptions are patients?. The manufacturers' viewpoint. J Allergy Clin Immunol 2010; 126: 668-669
8. Senti G, Graf N, Haug S, Ruedi N, von Moos S, Sonderegger T, Johansen P, Kundig TM. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 2009; 124: 997-1002
9. Senti G, Freiburghaus AU, Kundig TM. Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials. Curr Opin Allergy Clin Immunol 2010; 10: 582-586
10. Senti G, von Moos S, Kundig TM. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?. Allergy 2011; 66: 798-809
11. Agostinis F, Forti S, Di Berardino F. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy 2010; 65: 410-411
12. Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010; 125: 1165-1167
13. Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 1983; 80(suppl): 12s-16s
14. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000; 9: 165-169
15. Pilgram GS, van Der Meulen J, Gooris GS, Koerten HK, Bouwstra JA. The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim Biophys Acta 2001; 1511: 244-254
16. Pershing LK, Lambert LD, Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm Res 1990; 7: 170-175
17. Tupker RA, Pinnagoda J, Nater JP. The transient and cumulative effect of sodium lauryl sulphate on the epidermal barrier assessed by transepidermal water loss: inter-individual variation. Acta Derm Venereol 1990; 70: 1-5
18. Fang JY, Hung CF, Chiu HC, Wang JJ, Chan TF. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin. J Pharm Pharmacol 2003; 55: 1175
19. Denet AR, Vanbever R, Preat V. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 2004; 56: 659-674
20. Mitragotri S, Kost J. Low-frequency sonophoresis: a review. Adv Drug Deliv Rev 2004; 56: 589-601
21. Loffler H, Dreher F, Maibach HI. Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol 2004; 151: 746-752
22. Frerichs DM, Ellingsworth LR, Frech SA, Flyer DC, Villar CP, Yu J, Glenn GM. Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine 2008; 26: 2782-2787
23. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 1998; 87: 922-925
24. Coulman S, Allender C, Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst 2006; 23: 205-258
25. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain 2008; 24: 585-594
26. Duan D, Moeckly C, Gysbers J, Novak C, Prochnow G, Siebenaler K, Albers L, Hansen K. Enhanced delivery of topically-applied formulations following skin pre-treatment with a hand-applied, plastic microneedle array. Curr Drug Deliv 2011; 8: 557-565
27. Nordic Council on Medicines: Registration of Allergenic Preparations. Nordic guidelines, ed 2. Uppsala, NLN Publications, 1989, vol 23, pp 1-34
28. Heinzerling L, Mari A, Bergmann KC, Bresciani M, Burbach G, Darsow U, et al. The skin prick test -European standards. Clin Transl Allergy 2013; 3: 3
29. Liccardi G, D'Amato G, Canonica GW, Salzillo A, Piccolo A, Passalacqua G. Systemic reactions from skin testing: literature review. J Investig Allergol Clin Immunol 2006; 16: 75-78
30. Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?. J Control Release 2010; 148: 266-282
31. Dickel H, Goulioumis A, Gambichler T, Fluhr JW, Kamphowe J, Altmeyer P, Kuss O. Standardized tape stripping: a practical and reproducible protocol to uniformly reduce the stratum corneum. Skin Pharmacol Physiol 2010; 23: 259-265
32. Senti G, von Moos S, Tay F, Graf N, Sonderegger T, Johansen P, Kundig TM. Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: a double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol 2012; 129: 128-135
33. Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64(suppl 91): 1-59